Literature DB >> 3878608

Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies.

V Hornsey, L R Micklem, M C McCann, K James, J Dawes, D B McClelland, C V Prowse.   

Abstract

Five monoclonal antibodies to human von Willebrand factor were selected for characterization from 18 produced in murine hybridomas. All showed a high and specific affinity for human von Willebrand factor (vWf) but exhibited little if any cross-reaction with sera from other species. The antibodies defined four epitopes on vWf, none of which were involved in platelet binding. Binding of two distinct antibodies at one of these epitopes was associated with enhancement of the rate of vWf-dependent platelet agglutination in the presence of ristocetin. This effect was more noticeable when cryosupernatant plasma was used in place of normal plasma as the source of vWf, and was not explicable simply in terms of antibody-induced cross-linking of vWf.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878608

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assays.

Authors:  V S Hornsey; Y G Waterston; C V Prowse
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

2.  A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.

Authors:  I Tornai; J Arnout; H Deckmyn; K Peerlinck; J Vermylen
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

3.  Anti-vWf antibodies induce GPIbalpha and FcgammaRII mediated platelet aggregation only at low shear forces.

Authors:  M F Hoylaerts; A Viaene; C Thys; H Deckmyn; J Vermylen
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

4.  High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice.

Authors:  A L Archibald; M McClenaghan; V Hornsey; J P Simons; A J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.